Video-Assisted Anal Fistula Treatment (VAAFT) for complex anorectal fistula: efficacy and risk factors for failure at 3-year follow-up.


Journal

Techniques in coloproctology
ISSN: 1128-045X
Titre abrégé: Tech Coloproctol
Pays: Italy
ID NLM: 9613614

Informations de publication

Date de publication:
07 2020
Historique:
received: 21 01 2020
accepted: 07 04 2020
pubmed: 23 4 2020
medline: 28 4 2021
entrez: 23 4 2020
Statut: ppublish

Résumé

The aim of this study was to assess the 3-year objective and subjective outcomes of patients with complex anorectal fistula treated with Video-Assisted Anal Fistula Treatment (VAAFT). Furthermore, we evaluated the risk factors associated with recurrence. All consecutive patients with complex anorectal fistula who underwent VAAFT in Beata Vergine Hospital of Mendrisio, Switzerland, from January 2013 to January 2016, were enrolled. Patients with suspicion or diagnosis of Crohn's disease, malignancy, previous history of radiotherapy or radical pelvic surgery were excluded. Preoperative clinical assessment based upon medical history, physical examination and endosonography, was performed in all patients. Data regarding subjective outcomes (the Patient Global Impression of Improvement, patient satisfaction scores and Wexner score), objective cure rate (absence of fistula at clinical examination), and adverse events were collected during follow-up. Uni and multivariate analysis were performed to investigate outcomes. One hundred and four patients had VAAFT. At 3-year follow-up, 96 patients (92.3%) were available for the evaluation. At 3 years after surgery, 81 of 96 patients (84.4%) declared themselves cured (p = 0.60). Similarly, at 3-year evaluation, 80 of 96 patients (83.3%) were objectively cured (p = 0.52). No serious intraoperative or postoperative complications were reported. All recurrences were treated with a repeat VAAFT procedure resulting in a complete healing. Uni and multivariate analysis of variables potentially involved in the failure of VAAFT showed that age ≥ 50 years was the only factor associated at risk of recurrence. VAAFT is a highly effective safe procedure for the treatment of anorectal fistula, with a low recurrence rate at 3-year follow-up. However, our study demonstrated that age ≥ 50 years is a risk factor for failure of VAAFT.

Sections du résumé

BACKGROUND
The aim of this study was to assess the 3-year objective and subjective outcomes of patients with complex anorectal fistula treated with Video-Assisted Anal Fistula Treatment (VAAFT). Furthermore, we evaluated the risk factors associated with recurrence.
METHODS
All consecutive patients with complex anorectal fistula who underwent VAAFT in Beata Vergine Hospital of Mendrisio, Switzerland, from January 2013 to January 2016, were enrolled. Patients with suspicion or diagnosis of Crohn's disease, malignancy, previous history of radiotherapy or radical pelvic surgery were excluded. Preoperative clinical assessment based upon medical history, physical examination and endosonography, was performed in all patients. Data regarding subjective outcomes (the Patient Global Impression of Improvement, patient satisfaction scores and Wexner score), objective cure rate (absence of fistula at clinical examination), and adverse events were collected during follow-up. Uni and multivariate analysis were performed to investigate outcomes.
RESULTS
One hundred and four patients had VAAFT. At 3-year follow-up, 96 patients (92.3%) were available for the evaluation. At 3 years after surgery, 81 of 96 patients (84.4%) declared themselves cured (p = 0.60). Similarly, at 3-year evaluation, 80 of 96 patients (83.3%) were objectively cured (p = 0.52). No serious intraoperative or postoperative complications were reported. All recurrences were treated with a repeat VAAFT procedure resulting in a complete healing. Uni and multivariate analysis of variables potentially involved in the failure of VAAFT showed that age ≥ 50 years was the only factor associated at risk of recurrence.
CONCLUSIONS
VAAFT is a highly effective safe procedure for the treatment of anorectal fistula, with a low recurrence rate at 3-year follow-up. However, our study demonstrated that age ≥ 50 years is a risk factor for failure of VAAFT.

Identifiants

pubmed: 32318991
doi: 10.1007/s10151-020-02213-w
pii: 10.1007/s10151-020-02213-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

741-746

Références

Abcarian H (2011) Anorectal infection: abscess-fistula. Clin Colon Rectal Surg 24(1):14–21
doi: 10.1055/s-0031-1272819 pubmed: 22379401 pmcid: 3140329
Ramanujam PS et al (1984) Perianal abscesses and fistulas. A study of 1023 patients. Dis Colon Rectum 27(9):593
doi: 10.1007/BF02553848 pubmed: 6468199
Amato A, Bottini C, De Nardi P et al (2020) Evaluation and management of perianal abscess and anal fistula: SICCR position statement. Tech Coloproctol 24:127–143. https://doi.org/10.1007/s10151-019-02144-1.0
doi: 10.1007/s10151-019-02144-1.0 pubmed: 31974827
Sangwan YP et al (1994) Is simple fistula-in-ano simple? Dis Colon Rectum 37:885–889
doi: 10.1007/BF02052593 pubmed: 8076487
Meinero P, Mori L (2011) Video-assisted anal fistula treatment (VAAFT): a novel sphincter-saving procedure for treating complex anal fistulas. Tech Coloproctol 15(4):417–422
doi: 10.1007/s10151-011-0769-2 pubmed: 22002535 pmcid: 3226694
Rojanasakul A (2009) LIFT procedure: a simplified technique for fistula-in-ano. Tech Coloproctol 13:237–240
doi: 10.1007/s10151-009-0522-2 pubmed: 19636496
Lupinacci RM, Vallet C, Parc Y, Chafai N, Tiret E (2010) Treatment of fistula-in-ano with the Surgisis AFP(TM) anal fistula plug. Gastroenterol Clin Biol 34:549–553
doi: 10.1016/j.gcb.2009.06.021 pubmed: 20822873
Song KH (2012) New techniques for treating an anal fistula. J Korean Soc Coloproctol 28(1):7–12. https://doi.org/10.3393/jksc.2012.28.1.7
doi: 10.3393/jksc.2012.28.1.7 pubmed: 3296947 pmcid: 3296947
Garcia-Aguilar J, Belmonte C, Wong WD, Goldberg SM, Madoff RD (1996) Anal fistula surgery. Factors associated with recurrence and incontinence. Dis Colon Rectum 39(7):723–729
doi: 10.1007/BF02054434 pubmed: 8674361
Emile SH, Elfeki H, Shalaby M, Sakr A (2018) A systematic review and meta-analysis of the efficacy and safety of video-assisted anal fistula treatment (VAAFT). Surg Endosc 32:2084–2093
doi: 10.1007/s00464-017-5905-2 pubmed: 29052068
Seow-En I, Seow-Choen F, Koh PK (2016) An experience with video-assisted anal fistula treatment (VAAFT) with new insights into the treatment of anal fistulae. Tech Coloproctol 20(6):389–393. https://doi.org/10.1007/s10151-016-1450-6
doi: 10.1007/s10151-016-1450-6 pubmed: 27059492
Parks AG et al (1976) A classification of fistula-in-ano. Br J Surg 63:1–12
doi: 10.1002/bjs.1800630102 pubmed: 1267867
Yalcin I, Bump RC (2003) Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol 189(1):98–101
doi: 10.1067/mob.2003.379 pubmed: 12861145
Vaizey CJ, Carapeti E, Cahill JA, Kamm MA (1999) Prospective comparison of faecal incontinence grading systems. Gut 44:77–80
doi: 10.1136/gut.44.1.77 pubmed: 9862829 pmcid: 1760067
Takahashi-Monroy T, Morales M, Garcia-Osogobio S et al (2008) SECCA(R) procedure for the treatment of fecal incontinence: results of five-year follow-up. Dis Colon Rectum 51:355
doi: 10.1007/s10350-007-9169-0 pubmed: 18204954
Atkin GK et al (2011) For many high anal fistulas, lay open is still a good option. Tech Coloproctol 15:143–150
doi: 10.1007/s10151-011-0676-6 pubmed: 21431388
Mizrahi N, Wexner SD, Zmora O, Da Silva G, Efron J, Weiss EG, Vernava AM 3rd, Nogueras JJ (2002) Endorectal advancement flap: are there predictors of failure? Dis Colon Rectum 45(12):1616–1621
doi: 10.1007/s10350-004-7248-z pubmed: 12473884
Sonoda T, Hull T, Piedmonte MR, Fazio VW (2002) Outcomes of primary repair of anorectal and rectovaginal fistulas using the endorectal advancement flap. Dis Colon Rectum 45:1622
doi: 10.1007/s10350-004-7249-y pubmed: 12473885
Mentes BB et al (2004) Elastic one-stage cutting seton for the treatment of high anal fistulas: preliminary results. Tech Coloproctol 8(3):159–162
doi: 10.1007/s10151-004-0080-6 pubmed: 15654522
Shanwani A et al (2010) Ligation of the intersphincteric fistula tract (LIFT): a sphincter-saving technique for fistula-in-ano. Dis Colon Rectum 53:39–42
doi: 10.1007/DCR.0b013e3181c160c4 pubmed: 20010348
Lunniss PJ (2009) LIFT procedure: a simplified technique for fistula in ano. Tech Coloproctol 13(3):241–242
doi: 10.1007/s10151-009-0523-1 pubmed: 19633812
Sentovich SM (2003) Fibrin glue for anal fistulas: long-term results. Dis Colon Rectum 46(4):498–502
doi: 10.1007/s10350-004-6589-y pubmed: 12682544
Christoforidis D et al (2008) Treatment of complex anal fistulas with the collagen fistula plug. Dis Colon Rectum 51(10):1482–1487
doi: 10.1007/s10350-008-9374-5 pubmed: 18521674
Wilhelm A (2011) A new technique for sphincter-preserving anal fistula repair using a novel radial emitting laser probe. Tech Coloproctol 15:445–449
doi: 10.1007/s10151-011-0726-0 pubmed: 21845480
Wang D et al (2014) Risk factors for anal fistula: a case–control study. Tech Coloproctol 18(7):635–639
doi: 10.1007/s10151-013-1111-y pubmed: 24452294

Auteurs

L Regusci (L)

Department of General Surgery, EOC-Beata Vergine Hospital, Mendrisio, Switzerland.

F Fasolini (F)

Department of General Surgery, EOC-Beata Vergine Hospital, Mendrisio, Switzerland.

P Meinero (P)

Department of General Surgery, EOC-Beata Vergine Hospital, Mendrisio, Switzerland.

G Caccia (G)

Department of Obstetrics and Gynecology, EOC-Beata Vergine Hospital, Via Turconi 23 CP 1652, 6850, Mendrisio, Switzerland.

G Ruggeri (G)

Department of Obstetrics and Gynecology, EOC-Beata Vergine Hospital, Via Turconi 23 CP 1652, 6850, Mendrisio, Switzerland.

M Serati (M)

Department of Obstetrics and Gynecology, Del Ponte Hospital, University of Insubria, Varese, Italy.

A Braga (A)

Department of Obstetrics and Gynecology, EOC-Beata Vergine Hospital, Via Turconi 23 CP 1652, 6850, Mendrisio, Switzerland. andybraga@libero.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH